Sign In
Sign Out
My Account
Subscribe
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
Special reports
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 11, 1997
View Archived Issues
Novel fibrinogen antagonist from Merck & Co.
Read More
Merck & Co. continues to develop 5alpha-reductase inhibitors
Read More
Thomae prepares fibrinogen receptor antagonists
Read More
Chiral TNF inhibitors reported by Schering AG
Read More
Clinical pharmacokinetics of nicotine after oral, i.v. and rectal administration
Read More
SR-BI receptor implicated in HDL metabolism
Read More
Chimeric molecule shows promise as thrombolytic therapy
Read More
Clinical results reported for Novo Nordisk insulinotropic agent
Read More
Miglitol tested in specific population subgroups
Read More
Efficacy of pioglitazone demonstrated in NIDDM patients
Read More
Midodrine efficacy in diabetic patients with orthostatic hypotension
Read More
Vical's Leuvectin enters phase I/II for prostate cancer
Read More
NIH funds high-throughput screening in allergic inflammation and immunology by Cadus
Read More
FDA Oncologic Drugs Advisory Committee to review three NDAs in late June
Read More
Cortecs' H. pylori diagnostic approved in Japan
Read More
NitroMed issued U.S. patent covering NO delivery compounds
Read More
Corlopam and Lovenox scheduled for advisory committee review
Read More
Milkhaus initiates phase II trial for prostate cancer
Read More
Oncor completes PMA for breast cancer test
Read More
Antifibrotic collaboration announced by ArQule and FibroGen
Read More
Cel-Sci receives approval to begin Multikine trial in Canada
Read More
Successful phase III trials of Cytolex trigger milestone payment for Magainin
Read More
ABS forms alliance with Russian Academy of Sciences
Read More
Long-term Enbrel safe and effective in RA
Read More
Update on Alpha-Beta's acquisition and Betafectin trial results timeline
Read More
Nevirapine for prophylaxis of HIV infection
Read More
BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Biopharma M&A scorecard
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe